Explore evidence

19.3 %19.3% of the respondents had provided money for breast cancer screening.

Nigeriacancer du seinobserved 2018published 2023PloS onePubMeddocument of 14 observations

1.22 odds_ratioA novel breast cancer risk variant in region 10p15.1 has an odds ratio of 1.22 with a 95% confidence interval of 1.08–1.38 and a p-value of 0.0015 in women of African ancestry.

Nigeriacancer du seinpublished 2013Carcinogenesiseurope_pmcdocument of 4 observations

1.65 hazard_ratioTravel time ≥30 minutes was associated with an increased risk of death (hazard ratio, 1.65).

Nigeriacancer du seinobserved May 2009–January 2019published 2021CancerPubMeddocument of 7 observations

Serum leptin, total cholesterol, triglycerides, and LDL levels were higher (p < 0.05) in the breast cancer patients relative to control subjects.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

39 participantsThirty-nine out of 46 participants (85%) knew that a breast lump was a possible sign of breast cancer.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

33 participantsThirty-three out of 46 participants (72%) lacked knowledge of early symptoms and signs of breast cancer.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

23.4 odds_ratioOdds ratio for BRCA1 was 23.4 (95% CI, 7.4 to 73.9).

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

12.2 %Ten (12.2%) of the 82 breast cancer patients presented early.

Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations

59.2 scoreThe pre-intervention overall functional quality of life domain score was 59.2 ± 21.98 for the intervention group.

Nigeriacancer du seinpublished 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations

72 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 72% received chemotherapy.

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

23.2 %Nineteen (23.2%) of the breast cancer patients were seen during the second year of follow-up.

Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations

79.52 %264 (79.52%) of the respondents performed breast self-examination (BSE).

Nigeriacancer du seinpublished 2020West African journal of medicinePubMeddocument of 6 observations

0 p_valueRare germline mutations in MTCL1 were significantly associated with a higher contribution of the APOBEC C>T signature (p = 6.1 × 10⁻⁶).

Nigeriacancer du seinpublished 2019International journal of cancereurope_pmcdocument of 4 observations

25 %Breast cancer is the most prevalent cancer for women in Nigeria, representing 25% of all cancers in women.

Nigeriacancer du seinpublished 2024Cancer reports (Hoboken, N.J.)PubMed

26.6 kg/m2Post-menopausal women with breast cancer had significantly higher BMI (26.60 ± 5.17 kg/m²) compared to controls (22.73 ± 1.21 kg/m²), with P < 0.001.

Nigeriacancer du seinpublished 2021Nigerian journal of clinical practicePubMeddocument of 6 observations

29 %Chemotherapy contributed 29% of the total costs for breast cancer care.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

7 %Among all cases, 7.0% carried a loss-of-function mutation in BRCA1.

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

Nigeria reports the highest age-standardized mortality rate for breast cancer among African countries.

Nigeriacancer du seinpublished 2021Annals of global healthPubMeddocument of 7 observations

18 %Immunotherapy contributed 18% of the total costs for breast cancer care.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

11.4 %Only 11.4 percent of study participants had good knowledge of breast cancer.

Nigeriacancer du seinpublished 2023African health sciencesPubMeddocument of 4 observations

0.002 p_valuePALB2 was significantly associated with breast cancer (11 cases, zero controls; P = .002).

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

Many participants described the breast cancer treatment experience as unpleasant and painful, with side effects including nausea, insomnia, sore throat, and hair loss.

Nigeriacancer du seinpublished 2023African journal of reproductive healthPubMeddocument of 4 observations

13.06 scorePost-intervention mean BSE practice scores in the traditional method group increased to 13.06 ± 2.74.

Nigeriacancer du seinpublished 2024BMC cancerPubMeddocument of 11 observations

APTT was significantly shorter in breast cancer patients than in healthy controls.

Nigeriacancer du seinpublished 2021Cancer investigationPubMeddocument of 4 observations

0.64 AORWomen in the uppermost category of occupational physical activity had an adjusted odds ratio of 0.64 for breast cancer risk.

Nigeriacancer du seinpublished 2022Cancer epidemiologyPubMeddocument of 6 observations